News Chinese buyers interested in J&J diabetes devices business Decision follows J&J's decision to close Animas insulin pump business
Views & Analysis Lilly collaborating with digital firm in 'real world' diabet... Rivals Novo Nordisk, Sanofi, and AstraZeneca also offering digital health services.
News Lilly to research real world diabetes with digital health fi... Eli Lilly and digital health firm Livongo are to collaborate on real-world studies and develop new insights into diabetes.
News Medicare to fund Abbott's needle-free diabetes monitor Abbott's new glucose monitoring device could be used by millions of diabetes patients in the US after government-funded health schemes agreed to pay for it.
News Merck/Pfizer undercut rivals with newly approved diabetes dr... Steglatro cheaper than SGLT2 rivals from AZ and Lilly/Boehringer
News Lilly partners with Rimidi on digital diabetes management to... Pharmaceutical companies in the diabetes market are all investing in tech to help doctors and patients manage the condition.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
